Skip to main content

Articles

Page 16 of 19

  1. Good adherence to antiretroviral therapy is necessary to achieve the best virological response, lower the risk that drug resistance will develop, and reduce morbidity and mortality. Little is known about the r...

    Authors: Ayele Tiyou, Tefera Belachew, Fisehaye Alemseged and Sibhatu Biadgilign
    Citation: AIDS Research and Therapy 2010 7:39
  2. As second-line antiretroviral treatment (ART) becomes more accessible in resource-limited settings (RLS), the need for more affordable monitoring tools such as point-of-care viral load assays and simplified ge...

    Authors: Kim Steegen, Michelle Bronze, Elke Van Craenenbroeck, Bart Winters, Koen Van der Borght, Carole L Wallis, Wendy Stevens, Tobias F Rinke de Wit and Lieven J Stuyver
    Citation: AIDS Research and Therapy 2010 7:38
  3. During stavudine phase-out plan in developing countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofov...

    Authors: Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul, Wisit Prasithsirikul, Preecha Tantanathip, Busakorn Suntisuklappon, Anongnuch Narkksoksung, Samruay Nilkamhang and Somnuek Sungkanuparph
    Citation: AIDS Research and Therapy 2010 7:37
  4. Immune reconstitution inflammatory syndrome (IRIS) is an important complication of HAART in sub-Saharan Africa, where opportunistic infections (OIs) including mycobacteria and cryptococcus are common. The immu...

    Authors: Catherine M Worsley, Melinda S Suchard, Wendy S Stevens, Annelies Van Rie and David M Murdoch
    Citation: AIDS Research and Therapy 2010 7:36
  5. We present an innovative approach to healthcare worker (HCW) training using mobile phones as a personal learning environment.

    Authors: Maria Zolfo, David Iglesias, Carlos Kiyan, Juan Echevarria, Luis Fucay, Ellar Llacsahuanga, Inge de Waard, Victor Suàrez, Walter Castillo Llaque and Lutgarde Lynen
    Citation: AIDS Research and Therapy 2010 7:35
  6. Lipoprotein profiles in HIV-infected African women have not been well described. We assessed associations of lipoprotein levels and cardiovascular risk with HIV-infection and CD4 count in Rwandan women.

    Authors: Kathryn Anastos, François Ndamage, Dalian Lu, Mardge H Cohen, Qiuhu Shi, Jason Lazar, Venerand Bigirimana and Eugene Mutimura
    Citation: AIDS Research and Therapy 2010 7:34
  7. Few data are available to guide programmatic solutions to the overlapping problems of undernutrition and HIV infection. We evaluated the impact of food assistance on patient outcomes in a comprehensive HIV pro...

    Authors: Louise C Ivers, Yuchiao Chang, J Gregory Jerome and Kenneth A Freedberg
    Citation: AIDS Research and Therapy 2010 7:33
  8. The 516G > T polymorphism in exon 4 of the CYP2B6 gene has been associated with increased plasma Efavirenz (EFV) concentrations. EFV concentrations greater than the recommended therapeutic range have been associa...

    Authors: Verena Gounden, Chantal van Niekerk, Tracy Snyman and Jaya A George
    Citation: AIDS Research and Therapy 2010 7:32
  9. A correlation between increase in the integration of Human Immunodeficiency virus-1 (HIV-1) cDNA and cell death was previously established. Here we show that combination of peptides that stimulate integration ...

    Authors: Aviad Levin, Zvi Hayouka, Assaf Friedler and Abraham Loyter
    Citation: AIDS Research and Therapy 2010 7:31
  10. Effective antiretroviral therapy reduces HIV-1 RNA levels, improves CD4 T-cell counts, and lowers the risk of opportunistic infections and malignancies. Interleukin-2 (IL-2) has been shown to increase CD4 T-ce...

    Authors: Ronald J Bosch, Richard B Pollard, Alan Landay, Evgenia Aga, Lawrence Fox and Ronald Mitsuyasu
    Citation: AIDS Research and Therapy 2010 7:30
  11. This study aimed to evaluate the prevalence and predictors of AIDS-related complicated cryptococcal meningitis. The outcome was complicated cryptococcal meningitis: prolonged (≥ 14 days) altered mental status,...

    Authors: Edward R Cachay, Joseph Caperna, Amy M Sitapati, Hamta Jafari, Sean Kandel and William C Mathews
    Citation: AIDS Research and Therapy 2010 7:29
  12. HIV-1 Rev protein regulates the expression of HIV-1 transcripts by binding to a highly structured stem loop structure called the Rev Responsive Element (RRE) present in the genomic and partially spliced RNAs. ...

    Authors: Yogeshwar Sharma, Ujjwal Neogi, Vikas Sood, Snigdha Banerjee, Subodh Samrat, Ajay Wanchu, Surjit Singh and Akhil C Banerjea
    Citation: AIDS Research and Therapy 2010 7:28
  13. Nef is a 27 KDa HIV-1 accessory protein. It downregulates CD4 from infected cell surface, a mechanism critical for efficient viral replication and pathogenicity. Agents that antagonize the Nef-mediated CD4 dow...

    Authors: Yong-Jiu Jin, Xiaoping Zhang, Catherine Yi Cai and Steven J Burakoff
    Citation: AIDS Research and Therapy 2010 7:26
  14. Recent studies have shown that the current guidelines suggesting immunologic monitoring to determine response to highly active antiretroviral therapy (HAART) are inadequate. We assessed whether routinely colle...

    Authors: Bryan Lau, Geetanjali Chander, Stephen J Gange and Richard D Moore
    Citation: AIDS Research and Therapy 2010 7:25
  15. Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor a...

    Authors: Ujjwal Neogi, Sreenivasa B Prarthana, George D'Souza, Ayesha DeCosta, Vijesh S Kuttiatt, Udaykumar Ranga and Anita Shet
    Citation: AIDS Research and Therapy 2010 7:24
  16. Stavudine continues to be widely used in resource poor settings despite its toxicity. Our objective was to determine association between plasma stavudine concentrations and lipoatrophy, concentrations of gluco...

    Authors: Phumla Z Sinxadi, Jan-Stefan van der Walt, Helen M McIlleron, Motasim Badri, Peter J Smith, Joel A Dave, Naomi S Levitt and Gary Maartens
    Citation: AIDS Research and Therapy 2010 7:23
  17. At present, there is no effective vaccine or other approved product for the prevention of sexually transmitted human immunodeficiency virus type 1 (HIV-1) infection. It has been reported that women in resource...

    Authors: Carol S Lackman-Smith, Beth A Snyder, Katherine M Marotte, Mark C Osterling, Marie K Mankowski, Maureen Jones, Lourdes Nieves-Duran, Nicola Richardson-Harman, James E Cummins Jr and Brigitte E Sanders-Beer
    Citation: AIDS Research and Therapy 2010 7:22
  18. The search for disease biomarkers within human peripheral fluids has become a favorable approach to preventative therapeutics throughout the past few years. The comparison of normal versus disease states can i...

    Authors: Rachel Van Duyne, Irene Guendel, Kylene Kehn-Hall, Rebecca Easley, Zachary Klase, Chenglong Liu, Mary Young and Fatah Kashanchi
    Citation: AIDS Research and Therapy 2010 7:21
  19. Long-term survival of HIV-1 infected individuals is usually achieved by continuous administration of combination antiretroviral therapy (ART). An exception to this scenario is represented by HIV-1 infected non...

    Authors: Claudia J Dembek, Sarah Kutscher, Silvia Heltai, Simone Allgayer, Priscilla Biswas, Silvia Ghezzi, Elisa Vicenzi, Dieter Hoffmann, Peter Reitmeir, Giuseppe Tambussi, Johannes R Bogner, Paolo Lusso, Hans-J Stellbrink, Elena Santagostino, Thomas Vollbrecht, Frank D Goebel…
    Citation: AIDS Research and Therapy 2010 7:20
  20. Although access to antiretroviral therapy (ART) for the treatment of HIV has increased during the last decade, many patients are still in need of treatment. With limited funds to provide ART to millions of pat...

    Authors: Reshmie Ramautarsing and Jintanat Ananworanich
    Citation: AIDS Research and Therapy 2010 7:18
  21. This report represents the first exploratory study of Chinese men who provide commercial sex services to other men ("money boys") in Jilin Province, People's Republic of China, through a convenience sample dra...

    Authors: Xiangdong Meng, Allen F Anderson, Lu Wang, Zhihe Li, Wei Guo, Zixuan Lee, Huixin Jin and Yong Cai
    Citation: AIDS Research and Therapy 2010 7:17
  22. HIV-1 in genital secretions may be opsonized by several molecules including complement components. Opsonized HIV-1 by complement enhances the infection of various mucosal target cells, such as dendritic cells ...

    Authors: Mohammad-Ali Jenabian, Héla Saïdi, Charlotte Charpentier, Hicham Bouhlal, Dominique Schols, Jan Balzarini, Thomas W Bell, Guido Vanham and Laurent Bélec
    Citation: AIDS Research and Therapy 2010 7:16
  23. HIV-1 invades the central nervous system (CNS) in the context of acute infection, persists thereafter in the absence of treatment, and leads to chronic intrathecal immunoactivation that can be measured by the ...

    Authors: Lars Hagberg, Paola Cinque, Magnus Gisslen, Bruce J Brew, Serena Spudich, Arabella Bestetti, Richard W Price and Dietmar Fuchs
    Citation: AIDS Research and Therapy 2010 7:15
  24. To examine the outcomes of highly-active antiretroviral therapy (HAART) for individuals with free access to healthcare, we evaluated 2327 patients in a cohort study composed of military personnel and beneficia...

    Authors: Vincent C Marconi, Greg A Grandits, Amy C Weintrob, Helen Chun, Michael L Landrum, Anuradha Ganesan, Jason F Okulicz, Nancy Crum-Cianflone, Robert J O'Connell, Alan Lifson, Glenn W Wortmann and Brian K Agan
    Citation: AIDS Research and Therapy 2010 7:14
  25. Interventions to promote prevention and earlier diagnosis of severe symptomatic hyperlactataemia (SHL) were implemented in the Western Cape provincial antiretroviral programme (South Africa) from 2004. Interve...

    Authors: Charlotte Schutz, Andrew Boulle, Dave Stead, Kevin Rebe, Meg Osler and Graeme Meintjes
    Citation: AIDS Research and Therapy 2010 7:13
  26. After the introduction of highly active antiretroviral therapies (HAART), an increased incidence of insulin resistance, diabetes mellitus (DM), and cardiovascular diseases has been described. The impact of suc...

    Authors: Diego Serraino, Silvia Bruzzone, Antonella Zucchetto, Barbara Suligoi, Angela De Paoli, Simona Pennazza, Laura Camoni, Luigino Dal Maso, Paoli De Paoli and Giovanni Rezza
    Citation: AIDS Research and Therapy 2010 7:11
  27. South Africa, with its scientific capacity, good infrastructure and high HIV incidence rates, is ideally positioned to conduct large-scale HIV prevention trials. The HIV Prevention Research Unit of the South A...

    Authors: Gita Ramjee, Nicola Coumi, Nozizwe Dladla-Qwabe, Shay Ganesh, Sharika Gappoo, Roshini Govinden, Vijayanand Guddera, Rashika Maharaj, Jothi Moodley, Neetha Morar, Sarita Naidoo and Thesla Palanee
    Citation: AIDS Research and Therapy 2010 7:10
  28. Abacavir (ABC) treatment has been associated with an increased incidence of myocardial infarction. The pathophysiological mechanism is unknown. In this study markers of inflammation and coagulation in HIV-infe...

    Authors: Eefje Jong, Joost CM Meijers, Eric CM van Gorp, C Arnold Spek and Jan W Mulder
    Citation: AIDS Research and Therapy 2010 7:9
  29. Cytochrome P450 2B6 (CYP2B6) metabolizes efavirenz and nevirapine, the major core antiretroviral drugs for HIV in Thailand. Rifampicin, a critical component of tuberculosis (TB) therapy is a potent inducer of CYP...

    Authors: Sumonmal Uttayamakul, Sirirat Likanonsakul, Weerawat Manosuthi, Nuanjun Wichukchinda, Thareerat Kalambaheti, Emi E Nakayama, Tatsuo Shioda and Srisin Khusmith
    Citation: AIDS Research and Therapy 2010 7:8
  30. Current therapy for human immunodeficiency virus (HIV-1) infection relies primarily on the administration of anti-retroviral nucleoside analogues, either alone or in combination with HIV-protease inhibitors. A...

    Authors: Irene Guendel, Emmanuel T Agbottah, Kylene Kehn-Hall and Fatah Kashanchi
    Citation: AIDS Research and Therapy 2010 7:7
  31. Smoking prevalence in human immunodeficiency virus (HIV) positive subjects is about three times of that in the general population. However, whether the extremely high smoking prevalence in HIV-positive subject...

    Authors: Qu Cui, Sue Carruthers, Andrew McIvor, Fiona Smaill, Lehana Thabane and Marek Smieja
    Citation: AIDS Research and Therapy 2010 7:6
  32. Ritonavir-boosted saquinavir (SQVr) is nowadays regarded as an alternative antiretroviral drug probably due to several drawbacks, such as its high pill burden, twice daily dosing and the requirement of 200 mg ...

    Authors: Luis F López-Cortés, Pompeyo Viciana, Rosa Ruiz-Valderas, Juan Pasquau, Josefa Ruiz, Fernando Lozano, Dolores Merino, Antonio Vergara, Alberto Terrón, Luis González, Antonio Rivero and Agustin Muñoz-Sanz
    Citation: AIDS Research and Therapy 2010 7:5
  33. HIV-1 infected patients for whom standard gp160 phenotypic tropism testing failed are currently excluded from co-receptor antagonist treatment. To provide patients with maximal treatment options, massively par...

    Authors: Ina Vandenbroucke, Herwig Van Marck, Wendy Mostmans, Veerle Van Eygen, Evelien Rondelez, Kim Thys, Kurt Van Baelen, Katrien Fransen, Dolores Vaira, Kabamba Kabeya, Stephane De Wit, Eric Florence, Michel Moutschen, Linos Vandekerckhove, Chris Verhofstede and Lieven J Stuyver
    Citation: AIDS Research and Therapy 2010 7:4
  34. International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We es...

    Authors: Kjell Arne Johansson, Bjarne Robberstad and Ole Frithjof Norheim
    Citation: AIDS Research and Therapy 2010 7:3
  35. Adequate antiretroviral drug potency is essential for obtaining therapeutic benefit, however, the behavioral aspects of proper adherence and readiness to medication, often determine therapeutic outcome. Theref...

    Authors: Belay Tessema, Fantahun Biadglegne, Andargachew Mulu, Assefa Getachew, Frank Emmrich and Ulrich Sack
    Citation: AIDS Research and Therapy 2010 7:2
  36. A recent study reported a lower than expected specificity and positive predictive value of the rapid oral HIV test in the setting of routine emergency department (ED) screening. These results appeared inconsis...

    Authors: Jeremy Brown, Manya Magnus, Maggie Czarnogosrki and Vanessa Lee
    Citation: AIDS Research and Therapy 2010 7:1
  37. Different strategies of ritonavir-boosted lopinavir monotherapy have been explored; however, data regarding salvage therapy among HIV-infected patients who failed nucleoside reverse transcriptase inhibitor (NR...

    Authors: Weerawat Manosuthi, Sasisopin Kiertiburanakul, Wannarat Amornnimit, Wisit Prasithsirikul, Supeda Thongyen, Samruay Nilkamhang, Kiat Ruxrungtham and Somnuek Sungkanuparph
    Citation: AIDS Research and Therapy 2009 6:30
  38. Lopinavir/ritonavir (LPV/r) tablet compared to the soft gel capsule (SGC) formulation has no oleic acid or sorbitol, has no refrigeration or food-restriction requirements, and has less pharmacokinetic variabil...

    Authors: Ighovwerha Ofotokun, Susan K Chuck, Brian Schmotzer and Kelly L O'Neil
    Citation: AIDS Research and Therapy 2009 6:29
  39. HIV-1 epidemic in India is largely driven by subtype C but other subtypes or recombinants have also been reported from several states of India. This is mainly due to the co-circulation of other genetic subtype...

    Authors: Ujjwal Neogi, Vikas Sood, Arpita Chowdhury, Shukla Das, Vishnampettai G Ramachandran, Vijesh K Sreedhar, Ajay Wanchu, Nilanjana Ghosh and Akhil C Banerjea
    Citation: AIDS Research and Therapy 2009 6:28
  40. With the advent of entry inhibitors, monitoring of viral tropism in the clinical setting is important. Conventional methods are cell-based and lengthy, therefore V3 sequence based prediction algorithms are bec...

    Authors: Viswanath Ragupathy, Jiangqin Zhao, Xue Wang, Owen Wood, Sherwin Lee, Sherri Burda, Phillipe Nyambi and Indira Hewlett
    Citation: AIDS Research and Therapy 2009 6:27
  41. Fenofibrate changed the expression of chemokine genes in circulating leukocytes of HIV-infected patients with hypertriglyceridemia. The data suggest that fenofibrate when effective in the treatment of lipoprot...

    Authors: Carlos Alonso-Villaverde, Gerard Aragonès, Raúl Beltrán-Debón, Laura Fernández-Sender, Anna Rull, Jordi Camps, Josep M Alegret and Jorge Joven
    Citation: AIDS Research and Therapy 2009 6:26
  42. Snake and insect venoms have been demonstrated to have beneficial effects in the treatment of certain diseases including drug resistant human immunodeficiency virus (HIV) infection. We evaluated and hypothesiz...

    Authors: Ramachandran Meenakshisundaram, Shah Sweni and Ponniah Thirumalaikolundusubramanian
    Citation: AIDS Research and Therapy 2009 6:25
  43. WR1065 is the free-thiol metabolite of the cytoprotective aminothiol amifostine, which is used clinically at very high doses to protect patients against toxicity induced by radiation and chemotherapy. In an ea...

    Authors: Miriam C Poirier, Ofelia A Olivero, Andrew W Hardy, Genoveffa Franchini, Jennifer P Borojerdi, Vernon E Walker, Dale M Walker and Gene M Shearer
    Citation: AIDS Research and Therapy 2009 6:24
  44. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important category of drugs for both chemotherapy and prevention of human immunodeficiency virus type 1 (HIV-1) infection. However, current non-h...

    Authors: Yonghou Jiang, Baoping Tian, Mohammed Saifuddin, Michael B Agy, Peter Emau, J Scott Cairns and Che-Chung Tsai
    Citation: AIDS Research and Therapy 2009 6:23
  45. A high incidence of rash has been reported in HIV-1 patients who received the anti-retroviral drug nevirapine. In addition, several studies have suggested that polymorphisms of human leukocyte antigen (HLA) genes...

    Authors: Sirirat Likanonsakul, Tippawan Rattanatham, Siriluk Feangvad, Sumonmal Uttayamakul, Wisit Prasithsirikul, Preecha Tunthanathip, Emi E Nakayama and Tatsuo Shioda
    Citation: AIDS Research and Therapy 2009 6:22
  46. With African health-care systems facing exploding demand for HIV care, reliable methods for assessing adherence and its influencing factors are needed to guide effective public-health measures. This study eval...

    Authors: Mathieu Rougemont, Beat E Stoll, Nadia Elia and Peter Ngang
    Citation: AIDS Research and Therapy 2009 6:21
  47. HIV-1 infects gut associated lymphoid tissues (GALT) very early after transmission by multiple routes. The infected GALT consequently serves as the major reservoir for HIV-1 infection and could constantly shed...

    Authors: Ayan K Chakrabarti, Lori Caruso, Ming Ding, Chengli Shen, William Buchanan, Phalguni Gupta, Charles R Rinaldo and Yue Chen
    Citation: AIDS Research and Therapy 2009 6:20